APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Abuse Treatment

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Selected research

Market Structure

Global Drug Abuse Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchDrug Abuse Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Abuse Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Drug Abuse Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Abuse Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Abuse Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.

Report Includes

Read the full market overview

This report provides an overview of the global Drug Abuse Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Abuse Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Abuse Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Abuse Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Abuse Treatment Segment by Company

Indivior

Pfizer

Alkermes

Novartis

Mylan

Cipla

Glenmark

Dr. Reddy's Laboratories

Teva Pharmaceutical

PLIVA (Odyssey)

Drug Abuse Treatment Segment by Type

Opioid Addiction

Tobacco/Nicotine Addiction

Alcohol Dependence

Drug Abuse Treatment Segment by Application

Hospital & Clinics

Residential (non-hospital)

Drug Abuse Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Abuse Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Abuse Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Abuse Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Abuse Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Abuse Treatment industry.

Chapter 3: Detailed analysis of Drug Abuse Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Abuse Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Abuse Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Opioid Addiction Table 3. Key Players of Tobacco/Nicotine Addiction Table 4. Key Players of Alcohol Dependence Table 4. Global Drug Abuse Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital & Clinics Table 6. Key Players of Residential (non-hospital) Table 7. Global Drug Abuse Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Drug Abuse Treatment Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Drug Abuse Treatment Market Share by Region (2021-2026) Table 10. Global Drug Abuse Treatment Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Drug Abuse Treatment Market Share by Region (2027-2032) Table 12. Drug Abuse Treatment Industry Trends Table 13. Drug Abuse Treatment Industry Drivers Table 14. Drug Abuse Treatment Industry Opportunities and Challenges Table 15. Drug Abuse Treatment Industry Restraints Table 16. Global Drug Abuse Treatment Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Drug Abuse Treatment Revenue Market Share by Company (2021-2026) Table 18. Global Drug Abuse Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Drug Abuse Treatment Key Company Head Office and Area Served Table 20. Global Drug Abuse Treatment Company, Product Type & Application Table 21. Global Drug Abuse Treatment Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Drug Abuse Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Drug Abuse Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Drug Abuse Treatment Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Drug Abuse Treatment Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Drug Abuse Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Drug Abuse Treatment Revenue Market Share by Type (2027-2032) Table 29. Global Drug Abuse Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Drug Abuse Treatment Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Drug Abuse Treatment Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Drug Abuse Treatment Revenue Market Share by Application (2021-2026) Table 33. Global Drug Abuse Treatment Revenue Market Share by Application (2027-2032) Table 34. Indivior Company Information Table 35. Indivior Business Overview Table 36. Indivior Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Indivior Drug Abuse Treatment Product Portfolio Table 38. Indivior Recent Development Table 39. Pfizer Company Information Table 40. Pfizer Business Overview Table 41. Pfizer Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Pfizer Drug Abuse Treatment Product Portfolio Table 43. Pfizer Recent Development Table 44. Alkermes Company Information Table 45. Alkermes Business Overview Table 46. Alkermes Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Alkermes Drug Abuse Treatment Product Portfolio Table 48. Alkermes Recent Development Table 49. Novartis Company Information Table 50. Novartis Business Overview Table 51. Novartis Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Novartis Drug Abuse Treatment Product Portfolio Table 53. Novartis Recent Development Table 54. Mylan Company Information Table 55. Mylan Business Overview Table 56. Mylan Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Mylan Drug Abuse Treatment Product Portfolio Table 58. Mylan Recent Development Table 59. Cipla Company Information Table 60. Cipla Business Overview Table 61. Cipla Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Cipla Drug Abuse Treatment Product Portfolio Table 63. Cipla Recent Development Table 64. Glenmark Company Information Table 65. Glenmark Business Overview Table 66. Glenmark Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Glenmark Drug Abuse Treatment Product Portfolio Table 68. Glenmark Recent Development Table 69. Dr. Reddy's Laboratories Company Information Table 70. Dr. Reddy's Laboratories Business Overview Table 71. Dr. Reddy's Laboratories Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Dr. Reddy's Laboratories Drug Abuse Treatment Product Portfolio Table 73. Dr. Reddy's Laboratories Recent Development Table 74. Teva Pharmaceutical Company Information Table 75. Teva Pharmaceutical Business Overview Table 76. Teva Pharmaceutical Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Teva Pharmaceutical Drug Abuse Treatment Product Portfolio Table 78. Teva Pharmaceutical Recent Development Table 79. PLIVA (Odyssey) Company Information Table 80. PLIVA (Odyssey) Business Overview Table 81. PLIVA (Odyssey) Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. PLIVA (Odyssey) Drug Abuse Treatment Product Portfolio Table 83. PLIVA (Odyssey) Recent Development Table 84. North America Drug Abuse Treatment Market Size by Type (2021-2026) & (US$ Million) Table 85. North America Drug Abuse Treatment Market Size by Type (2027-2032) & (US$ Million) Table 86. North America Drug Abuse Treatment Market Size by Application (2021-2026) & (US$ Million) Table 87. North America Drug Abuse Treatment Market Size by Application (2027-2032) & (US$ Million) Table 88. North America Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Drug Abuse Treatment Market Size by Country (2021-2026) Table 90. North America Drug Abuse Treatment Market Size by Country (2027-2032) Table 91. Europe Drug Abuse Treatment Market Size by Type (2021-2026) & (US$ Million) Table 92. Europe Drug Abuse Treatment Market Size by Type (2027-2032) & (US$ Million) Table 93. Europe Drug Abuse Treatment Market Size by Application (2021-2026) & (US$ Million) Table 94. Europe Drug Abuse Treatment Market Size by Application (2027-2032) & (US$ Million) Table 95. Europe Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Drug Abuse Treatment Market Size by Country (2021-2026) Table 97. Europe Drug Abuse Treatment Market Size by Country (2027-2032) Table 98. China Drug Abuse Treatment Market Size by Type (2021-2026) & (US$ Million) Table 99. China Drug Abuse Treatment Market Size by Type (2027-2032) & (US$ Million) Table 100. China Drug Abuse Treatment Market Size by Application (2021-2026) & (US$ Million) Table 101. China Drug Abuse Treatment Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Drug Abuse Treatment Market Size by Type (2021-2026) & (US$ Million) Table 103. Asia Drug Abuse Treatment Market Size by Type (2027-2032) & (US$ Million) Table 104. Asia Drug Abuse Treatment Market Size by Application (2021-2026) & (US$ Million) Table 105. Asia Drug Abuse Treatment Market Size by Application (2027-2032) & (US$ Million) Table 106. Asia Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Drug Abuse Treatment Market Size by Country (2021-2026) Table 108. Asia Drug Abuse Treatment Market Size by Country (2027-2032) Table 109. South America, Middle East & Africa Drug Abuse Treatment Market Size by Type (2021-2026) & (US$ Million) Table 110. South America, Middle East & Africa Drug Abuse Treatment Market Size by Type (2027-2032) & (US$ Million) Table 111. South America, Middle East & Africa Drug Abuse Treatment Market Size by Application (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Drug Abuse Treatment Market Size by Application (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. South America, Middle East & Africa Drug Abuse Treatment Market Size by Country (2021-2026) Table 115. South America, Middle East & Africa Drug Abuse Treatment Market Size by Country (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Drug Abuse Treatment Product Image Figure 2. Global Drug Abuse Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drug Abuse Treatment Market Share by Type: 2025 VS 2032 Figure 4. Opioid Addiction Image Figure 5. Tobacco/Nicotine Addiction Image Figure 6. Alcohol Dependence Image Figure 7. Global Drug Abuse Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Drug Abuse Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospital & Clinics Image Figure 10. Residential (non-hospital) Image Figure 11. Global Drug Abuse Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Drug Abuse Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Drug Abuse Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Drug Abuse Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drug Abuse Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Abuse Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Drug Abuse Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drug Abuse Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Drug Abuse Treatment Market Share by Type (2021-2032) Figure 24. North America Drug Abuse Treatment Market Share by Application (2021-2032) Figure 25. North America Drug Abuse Treatment Market Share by Country (2021-2032) Figure 26. United States Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Drug Abuse Treatment Market Share by Type (2021-2032) Figure 31. Europe Drug Abuse Treatment Market Share by Application (2021-2032) Figure 32. Europe Drug Abuse Treatment Market Share by Country (2021-2032) Figure 33. Germany Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Drug Abuse Treatment Market Share by Type (2021-2032) Figure 41. China Drug Abuse Treatment Market Share by Application (2021-2032) Figure 42. Asia Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Drug Abuse Treatment Market Share by Type (2021-2032) Figure 44. Asia Drug Abuse Treatment Market Share by Application (2021-2032) Figure 45. Asia Drug Abuse Treatment Market Share by Country (2021-2032) Figure 46. Japan Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Drug Abuse Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Drug Abuse Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Drug Abuse Treatment Market Share by Country (2021-2032) Figure 56. Brazil Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Drug Abuse Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Opioid Addiction
  • Tobacco/Nicotine Addiction
  • Alcohol Dependence
Applications
  • Hospital & Clinics
  • Residential (non-hospital)
Companies covered
  • Indivior
  • Pfizer
  • Alkermes
  • Novartis
  • Mylan
  • Cipla
  • Glenmark
  • Dr. Reddy's Laboratories
  • Teva Pharmaceutical
  • PLIVA (Odyssey)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drug Abuse Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Opioid Addiction
  5. 1.2.3 Tobacco/Nicotine Addiction
  6. 1.2.4 Alcohol Dependence
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Drug Abuse Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital & Clinics
  10. 1.3.3 Residential (non-hospital)
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Drug Abuse Treatment Growth Trends by Region
  13. 1.5.1 Global Drug Abuse Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Drug Abuse Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Drug Abuse Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Drug Abuse Treatment Market Dynamics
  1. 2.1 Drug Abuse Treatment Industry Trends
  2. 2.2 Drug Abuse Treatment Industry Drivers
  3. 2.3 Drug Abuse Treatment Industry Opportunities and Challenges
  4. 2.4 Drug Abuse Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drug Abuse Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Drug Abuse Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drug Abuse Treatment Key Company Head office and Area Served
  4. 3.4 Global Drug Abuse Treatment Company, Product Type & Application
  5. 3.5 Global Drug Abuse Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drug Abuse Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drug Abuse Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drug Abuse Treatment Tier 1, Tier 2, and Tier 3
4 Drug Abuse Treatment Market by Type
  1. 4.1 Global Drug Abuse Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drug Abuse Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Drug Abuse Treatment Market Size Share by Type (2021-2032)
5 Drug Abuse Treatment Market by Application
  1. 5.1 Global Drug Abuse Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Abuse Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Drug Abuse Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Indivior
  2. 6.1.1 Indivior Company Information
  3. 6.1.2 Indivior Business Overview
  4. 6.1.3 Indivior Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Indivior Drug Abuse Treatment Product Portfolio
  6. 6.1.5 Indivior Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Drug Abuse Treatment Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Alkermes
  14. 6.3.1 Alkermes Company Information
  15. 6.3.2 Alkermes Business Overview
  16. 6.3.3 Alkermes Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Alkermes Drug Abuse Treatment Product Portfolio
  18. 6.3.5 Alkermes Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Drug Abuse Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Mylan Drug Abuse Treatment Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cipla Drug Abuse Treatment Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Glenmark
  38. 6.7.1 Glenmark Company Information
  39. 6.7.2 Glenmark Business Overview
  40. 6.7.3 Glenmark Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Glenmark Drug Abuse Treatment Product Portfolio
  42. 6.7.5 Glenmark Recent Developments
  43. 6.8 Dr. Reddy's Laboratories
  44. 6.8.1 Dr. Reddy's Laboratories Company Information
  45. 6.8.2 Dr. Reddy's Laboratories Business Overview
  46. 6.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Dr. Reddy's Laboratories Drug Abuse Treatment Product Portfolio
  48. 6.8.5 Dr. Reddy's Laboratories Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Drug Abuse Treatment Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 PLIVA (Odyssey)
  56. 6.10.1 PLIVA (Odyssey) Company Information
  57. 6.10.2 PLIVA (Odyssey) Business Overview
  58. 6.10.3 PLIVA (Odyssey) Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 PLIVA (Odyssey) Drug Abuse Treatment Product Portfolio
  60. 6.10.5 PLIVA (Odyssey) Recent Developments
7 North America
  1. 7.1 North America Drug Abuse Treatment Market Size (2021-2032)
  2. 7.2 North America Drug Abuse Treatment Market Size by Type
  3. 7.2.1 North America Drug Abuse Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Drug Abuse Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Drug Abuse Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Drug Abuse Treatment Market Size by Application
  7. 7.3.1 North America Drug Abuse Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Drug Abuse Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Drug Abuse Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Drug Abuse Treatment Market Size by Country
  11. 7.4.1 North America Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drug Abuse Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Drug Abuse Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Drug Abuse Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drug Abuse Treatment Market Size (2021-2032)
  2. 8.2 Europe Drug Abuse Treatment Market Size by Type
  3. 8.2.1 Europe Drug Abuse Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drug Abuse Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drug Abuse Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Drug Abuse Treatment Market Size by Application
  7. 8.3.1 Europe Drug Abuse Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drug Abuse Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drug Abuse Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Drug Abuse Treatment Market Size by Country
  11. 8.4.1 Europe Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drug Abuse Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drug Abuse Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drug Abuse Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drug Abuse Treatment Market Size (2021-2032)
  2. 9.2 China Drug Abuse Treatment Market Size by Type
  3. 9.2.1 China Drug Abuse Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Drug Abuse Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Drug Abuse Treatment Market Share by Type (2021-2032)
  6. 9.3 China Drug Abuse Treatment Market Size by Application
  7. 9.3.1 China Drug Abuse Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Drug Abuse Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Drug Abuse Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drug Abuse Treatment Market Size (2021-2032)
  2. 10.2 Asia Drug Abuse Treatment Market Size by Type
  3. 10.2.1 Asia Drug Abuse Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drug Abuse Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drug Abuse Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Drug Abuse Treatment Market Size by Application
  7. 10.3.1 Asia Drug Abuse Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drug Abuse Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drug Abuse Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Drug Abuse Treatment Market Size by Country
  11. 10.4.1 Asia Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drug Abuse Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drug Abuse Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drug Abuse Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drug Abuse Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drug Abuse Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drug Abuse Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drug Abuse Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drug Abuse Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drug Abuse Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drug Abuse Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drug Abuse Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drug Abuse Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drug Abuse Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drug Abuse Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drug Abuse Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drug Abuse Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drug Abuse Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst